Date(s) - 5 Oct 2021
9:30 AM - 3:00 PM
Professor in the Applied Cancer Research and Drug Discovery Division at TGen and Chief Medical Officer of the International Myeloma Foundation (IMF)
CHRIS GLEMBOTSKI, PHD
Professor, Department of Internal Medicine, Director, Translational Cardiovascular Research Center and Associate Dean, Research, College of Medicine, Phoenix, UA
PETRA FROMME, PHD
Director and Professor, Biodesign Center for Applied Structural Discovery, ASU
ANIL NAIR, PHD
Vice President, in silico drug discovery at Ligand Pharmaceuticals
STEFFAN NAWROCKI, PHD
Associate Professor, Cancer Biology – GIDP, and Research Director – Medical Oncology, College of Medicine, Tucson, UA
MICHAEL KUHNS, PHD
Associate Professor, Immunobiology, College of Medicine, Tucson, UA
DONNA ZHANG, PHD
Musil Family Endowed Chair in Drug Discovery and Professor Pharmacology and Toxicology, College of Pharmacy, Tucson, UA
Dean & Professor, College of Pharmacy
JOANN SWEASY, PHD
Director, University of Arizona Cancer Center Nancy C. and Craig M. Berge Endowed Chair Professor, Cellular and Molecular Medicine Professor, Radiation Oncology
WILLIAM R. MONTFORT, PHD
Clinical and Translational Oncology Program Co-Leader, University of Arizona Cancer Center; Professor, Chemistry and Biochemistry-Sci, Colleges of Science and Medicine – Tuc
WEI WANG, PHD
Co-Director, ACDD, Professor, Pharmacology & Toxicology, College of Pharmacy
CELINA ZERBINATTI, PHD
Co-Director, ACDD; Associate Professor, Department of Pharmacology & Toxicology
Welcome: 9:30 – 9:35 a.m.
Morning Session: 9:35 a.m. – 12:25 p.m.
Afternoon Session: 1:10 – 3:00 p.m.
Closing Remarks: 2:55 – 3:00 p.m.